9
Total investments
2
Early stage
2
Mid stage
1
Late stage
31y
Years active
Portfolio
8 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jan 2024
Were an AI research company that builds reliable, interpretable, and steerable AI systems. Our first product is Claude, an AI assistant for tasks at any scale.
Our research interests span multiple areas including natural language, human feedback, scaling laws, reinforcement learning, code generation, and interpretability.
Board Member
Jun 2023
Cato provides a world-leading single-vendor SASE platform. Cato creates a seamless and elegant customer experience that effortlessly enables threat prevention, data protection, and timely incident detection and response. Using Cato, businesses easily replace costly and rigid legacy infrastructure with an open and modular SASE architecture based on SD-WAN, a purpose-built global cloud network, and an embedded cloud-native security stack to secure and optimize their global hybrid workforce and mission-critical applications and data on premises and in the cloud. With Cato, any organization can reap the full benefits of digital transformation and move at the speed of business.
Investor, Board Observer
Aug 2012
Zscaler (NASDAQ: ZS) is a pioneer and global leader in zero trust security. The world’s largest businesses, critical infrastructure organizations, and government agencies rely on Zscaler to secure users, branches, applications, data & devices, and to accelerate digital transformation initiatives. Distributed across 160+ data centers globally, the Zscaler Zero Trust Exchange™ platform combined with advanced AI combats billions of cyber threats and policy violations every day and unlocks productivity gains for modern enterprises by reducing costs and complexity.
Stay Connected:
LinkedIn: https://www.linkedin.com/company/zscaler
Twitter: https://www.twitter.com/zscaler
Facebook: https://www.facebook.com/Zscaler/
Instagram: https://www.instagram.com/zscalerinc/
Early Investor
Jun 2011
We are no longer AppSense, we are Ivanti! Follow our new home at https://www.linkedin.com/company/ivanti.
Early investor, Board Observer
Apr 2008
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, weve pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.
#TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy.
Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team.
Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California.
Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.
https://www.natera.com/privacy/
Early investor, Board Observer
Oct 2002
Riverbed is the only company with the collective richness of telemetry from network to app to end user that illuminates and then accelerates every interaction so that users get the flawless digital experience they expect across the entire digital ecosystem. Riverbed provides two industry-leading solutions: the Riverbed Unified Observability portfolio, which integrates data, insights, and actions across IT to enable customers to deliver seamless digital experiences; and Riverbed Acceleration, which offers fast, agile, and secure acceleration of any application over any network to users, whether they are mobile, remote, or on-premises. Together with our thousands of partners, and market-leading customers across the world, we empower every click, every digital experience. Riverbed. Empower the Experience.
Board Observer
Feb 1997
Verio is the leading provider of innovative online business solutions for SMBs worldwide. Services include IaaS, cloud and SaaS products, online business tools, and hosting solutions. As a subsidiary of NTT Communications, Verio supports its operations with NTT’s highly reliable and scalable Global Tier-1 IP Network and 150 global datacenters.
Experience · 10 entries
All (10)
Investments (9)
Founder (1)
Board (6)
2024
Investor
Jan 2024
Were an AI research company that builds reliable, interpretable, and steerable AI systems. Our first product is Claude, an AI assistant for tasks at any scale.
Our research interests span multiple areas including natural language, human feedback, scaling laws, reinforcement learning, code generation, and interpretability.
2023
Board Member
Jun 2023
Cato provides a world-leading single-vendor SASE platform. Cato creates a seamless and elegant customer experience that effortlessly enables threat prevention, data protection, and timely incident detection and response. Using Cato, businesses easily replace costly and rigid legacy infrastructure with an open and modular SASE architecture based on SD-WAN, a purpose-built global cloud network, and an embedded cloud-native security stack to secure and optimize their global hybrid workforce and mission-critical applications and data on premises and in the cloud. With Cato, any organization can reap the full benefits of digital transformation and move at the speed of business.
2012
Investor, Board Observer
Aug 2012
Zscaler (NASDAQ: ZS) is a pioneer and global leader in zero trust security. The world’s largest businesses, critical infrastructure organizations, and government agencies rely on Zscaler to secure users, branches, applications, data & devices, and to accelerate digital transformation initiatives. Distributed across 160+ data centers globally, the Zscaler Zero Trust Exchange™ platform combined with advanced AI combats billions of cyber threats and policy violations every day and unlocks productivity gains for modern enterprises by reducing costs and complexity.
Stay Connected:
LinkedIn: https://www.linkedin.com/company/zscaler
Twitter: https://www.twitter.com/zscaler
Facebook: https://www.facebook.com/Zscaler/
Instagram: https://www.instagram.com/zscalerinc/
2011
Early Investor
Jun 2011
We are no longer AppSense, we are Ivanti! Follow our new home at https://www.linkedin.com/company/ivanti.
2008
Early investor, Board Observer
Apr 2008
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, weve pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.
#TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy.
Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team.
Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California.
Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.
https://www.natera.com/privacy/
Show all 10 entries ↓
Investment activity
1995–2024 · 9 investments
Recent (last 2 years)Earlier
